MedPath

Re-engineering the Clinical Approach to Suspected Cardiac Chest Pain Assessment in the ...

The RAPIDxAI trial found that an AI-based clinical decision support tool did not improve 6-month CV outcomes in patients with elevated hs-cTn but enhanced rates of evidence-based care without increasing adverse events.


Related News

Re-engineering the Clinical Approach to Suspected Cardiac Chest Pain Assessment in the ...

The RAPIDxAI trial found that an AI-based clinical decision support tool did not improve 6-month CV outcomes in patients with elevated hs-cTn but enhanced rates of evidence-based care without increasing adverse events.

© Copyright 2025. All Rights Reserved by MedPath